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Functionally exhausted T cells have high expression
of the PD-1 inhibitory receptor, and therapies that
block PD-1 signaling show promise for resolving
chronic viral infections and cancer. By using human
and murine systems of acute and chronic viral infec-
tions, we analyzed epigenetic regulation of PD-1
expression during CD8+ T cell differentiation. During
acute infection, naive to effector CD8+ T cell differen-
tiation was accompanied by a transient loss of DNA
methylation of the Pdcd1 locus that was directly
coupled to the duration and strength of T cell
receptor signaling. Further differentiation into func-
tional memory cells coincidedwithPdcd1 remethyla-
tion, providing an adapted program for regulation of
PD-1 expression. In contrast, the Pdcd1 regulatory
region was completely demethylated in exhausted
CD8+ T cells and remained unmethylated even
when virus titers decreased. This lack of DNA reme-
thylation leaves the Pdcd1 locus poised for rapid
expression, potentially providing a signal for prema-
ture termination of antiviral functions.
INTRODUCTION
Heritable changes in gene regulation that occur via modification
of the DNA without changing the DNA sequence are often
referred to as epigenetic programming. The major eukaryotic
mechanisms for epigenetic programming include DNA methyla-
tion, histone modifications, and noncoding RNA-mediated
transcriptional and posttranscriptional regulation (Li, 2002; Ting
et al., 2006). The best-understood and most extensively studied
epigenetic mechanism is transcriptional repression via DNA
methylation (Bestor et al., 1988; Holliday and Pugh, 1975; John-
son and Coghill, 1925; Jones and Liang, 2009; Klose and Bird,400 Immunity 35, 400–412, September 23, 2011 ª2011 Elsevier Inc.2006). Heritable transcriptional programming through DNA
methylation in conjunction with other epigenetic mechanisms
orchestrate tissue- and locus-specific chromatin access,
including chromatin remodeling events involved in T cell differen-
tiation (Ansel et al., 2006; Hutchins et al., 2002; Wilson et al.,
2009).
Epigenetic reprogramming has emerged as a mechanism to
explain the cell-transmissible nature of the acquired functional
properties in self-renewing memory CD8+ T cells (Ansel et al.,
2006; Kersh et al., 2006; Reiner, 2005; Youngblood et al.,
2010). After vaccination or infection, antigen-specific naive
CD8+ T cells rapidly expand and differentiate into cytotoxic
effector cells that produce cytokines to facilitate the control
and clearance of the pathogen. After clearance of the pathogen,
the antigen-specific cell population shifts to a state of prepared-
ness with the emergence of highly functional memory cells
(Ahmed and Gray, 1996; Bevan and Goldrath, 2000; Lefrancois
and Masopust, 2002). In contrast, chronic viral infection results
in a functional impairment referred to as T cell exhaustion.
CD8+ T cell exhaustion is characterized by the diminished ability
of the cell to express the cytokines IFN-g, TNF-a, and IL-2,
reduced cytotoxicity, and an impaired ability to proliferate
(Wherry et al., 2003; Zajac et al., 1998). Recent studies have re-
ported that naive, effector, functional memory, and exhausted
CD8+ T cells each have a distinct gene expression profile that
reflects their status of differentiation, indicating that many of
the functional differences between these T cell populations are
manifest through changes in transcriptional programming (Ansel
et al., 2003; Kaech et al., 2002; Reiner, 2005; Sarkar et al., 2008;
Wherry et al., 2007). Specifically, expression of the inhibitory
receptor PD-1 exemplifies the dynamic and differential gene
regulation that occurs during memory CD8+ T cell differentiation
and directly influences the functional capacity of these cells.
PD-1 is a cell surface receptor in the immunomodulatory family
of CD28 receptors. Expression of PD-1 is mainly restricted to
activated lymphocytes and provides a negative signal that
counters the activation signal provided by T cell receptor ligation
(Greenwald et al., 2005; Okazaki and Honjo, 2007). Signaling
through PD-1 is initiated by binding of its Ig surface domain to
Figure 1. Conserved Regions of the PDCD1
Promoter Contain Differentially Methylated
Sites that Correlate with PD-1 Expression
(A) The PDCD1 gene contains several highly
conserved regions as determined by the UCSC
Genome Browser (http://genome.ucsc.edu/)
(Karolchik et al., 2003) and a CpG island in the
human genome as defined by CpG Plot from the
European Bioinformatics Institute.
(B) Genomic DNA from EL4 (PD-1hi) and A20
(PD-1lo) was digested with either HpaII (H, meth-
ylation sensitive) or MspI (M, nonsensitive) along
with HindIII (HIII, nonsensitive). A Southern blot
of the methylation-sensitive restriction endonu-
clease challenge showing an undigested Hind III
fragment from A20 cells (arrowhead). The cartoon
of the promoter region displays the approximate
location of the restriction cut sites.
(C) Bisulfite sequencing of conserved region C
(CR-C) and CR-Bwas performed on genomic DNA
from A20 and EL4 cells. Each line represents an
individual clone picked for sequencing. Filled
circles indicate methylated cytosine; open circles
indicate nonmethylated cytosine.
(D) Peripheral blood CD8+ T cells were column
purified to >95% purity and stimulated with anti-
CD3/CD28 beads for 3 days. Stimulated cells were
cultured for an additional 5 days with and without
5-aza-20-deoxycytidine. Cells were harvested and
analyzed by FACS for PD-1 and CD8 expression.
(E) PD-1 mRNA from the indicated CD8+ T cell
population were analyzed with qRT-PCR. The
values obtained were normalized to 18S rRNA and
expressed as fold over the amount of transcript
from day 0 cells. Error bars were generated with
the SEM from triplicate experiments.
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Epigenetic Regulation of PD-1 in CD8+ T Cellsits ligands (PD-L1 and PD-L2) on infected (or antigen-presenting)
cells, ultimately blockingmany effector functions of the activated
T cell (Okazaki and Honjo, 2007; Riley, 2009; Sharpe et al., 2007).
Recently, via the mouse model of infection with lymphocytic
choriomeningitis virus (LCMV), it was shown that exhausted
antigen-specific CD8+ T cells generated in chronically infected
mice express high amount of PD-1 whereas functional antigen-
specific memory T cells in acutely infected mice have reduced
expression of PD-1. Treatment of chronically infected mice
with a PD-1 blocking antibody drastically improved T cell func-
tion and reduced viral load (Barber et al., 2006; Blackburn
et al., 2008). PD-1’s causal role in T cell exhaustion and the ther-
apeutic potential by blocking PD-1 signaling has been expanded
to nonhuman primate and human studies (Boettler et al., 2006;
Day et al., 2006; Golden-Mason et al., 2007; Kaufmann and
Walker, 2009; Radziewicz et al., 2007; Trautmann et al., 2006;
Urbani et al., 2006; Velu et al., 2009; Zhang et al., 2009).
In addition to blocking PD-1 signaling, modulating PD-1
expression may also serve to rejuvenate exhausted T cells.
To better define the manner by which Pdcd1 is regulated in
antigen-specific CD8+ T cells during acute and chronic infection,
we have examined DNA methylation of PD-1 transcriptional
regulatory regions in human and murine virus-specific CD8+
T cells during acute and chronic infection. We present dataImthat reveal an antigen-driven transcriptional program that is
distinct between exhausted and functional memory CD8+ T cells.
RESULTS
Identification of Epigenetic Regulatory Regions
in the PDCD1 Locus
Because of the important impact PD-1 has on CD8+ T cell func-
tion, we wished to determine the transcriptional mechanisms
involved in regulating expression of the gene encoding PD-1
(PDCD1). Bioinformatic analysis of the upstream DNA sequence
of the transcriptional start site of the human PDCD1 gene
revealed a putative CpG island, a CpG-rich genomic region
associated with DNA methylation-mediated transcriptional
repression, that overlaps with previously identified conserved
regions C and B (CR-C and CR-B) (Figure 1A). To test whether
CpG demethylation correlated with PD-1 expression, we exam-
ined themethylation status of CpGs at CR-C and -B in themouse
T cell line EL4 (which expresses high amounts of PD-1 transcript
and protein) and the mouse B cell line A20 (which produces very
little PD-1 transcript and protein) (Figure 1B; Oestreich et al.,
2008). By using a restriction digest analysis relying on enzymes
that are sensitive to CpG methylation, we determined that
the PDCD1-conserved regions in A20 cells (PD-1) containedmunity 35, 400–412, September 23, 2011 ª2011 Elsevier Inc. 401
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(PD-1hi) (Figure 1B). To obtain nucleotide resolution of DNA
methylation, we performed bisulfite sequencing of CR-C
and -B on genomic DNA from EL4 and A20 cells. EL4 cells
were found to be void of CpG methylation whereas A20 cells
displayed near-complete methylation in the Pdcd1-conserved
regions (Figure 1C). The observed inverse correlation of PD-1
expression with CpG methylation of CR-C and -B in cell lines
provides evidence that Pdcd1 transcriptional regulation is in
part mediated through site-specific DNA methylation.
To determine whether DNA methylation is causal in PD-1
repression, we measured PD-1 expression on in vitro activated
primary CD8+ T cells cultured in the presence and absence of
the DNA demethylating agent 5-aza-20-deoxycytidine (50AzaC).
Polyclonal human naive CD8+ T cells rapidly produce PD-1
when cultured in the presence of anti-CD3 and anti-CD28
(Figures 1D and 1E). In vitro activated CD8+ T cells were cultured
for 8 days with and without 50AzaC. Indeed, treatment of the
activated CD8+ T cells with 50AzaC resulted in retained expres-
sion of PD-1 protein and transcript (Figures 1D and 1E). Taken
together, these data suggest that the DNA methylation status
is inversely correlated with expression of PD-1. Further, these
data indicate that DNA methylation serves to repress PD-1
expression after TCR activation.
Dynamic Regulation of the Pdcd1 Locus during
Memory CD8+ T Cell Differentiation
We next sought to determine whether alterations in DNAmethyl-
ation programming are coupled to the dynamic PD-1 expression
that occurs during the differentiation of antigen-specific CD8+
T cell in response to in vivo viral infection. To investigate the
role of DNA methylation in the transcriptional regulation of
PD-1 expression in the differentiation of virus-specific T cells,
we used the mouse model of acute viral infection with LCMV
Armstrong. During acute LCMV infection, PD-1 expression is
upregulated in antigen-specific CD8+ T cells by 4 days postinfec-
tion near the peak of viremia and downregulated between day 4
and day 8 after viral clearance (Figure 2A; Ahmed et al., 1984;
Barber et al., 2006; Wherry et al., 2003, 2007). The transient
increase in PD-1 protein expression is coupled to an increase
in Pdcd1 transcriptional activity during early effector stages of
differentiation and ensuing downregulation of Pdcd1 transcrip-
tional activity in day 8 effector CD8+ T cells and throughout
the maintenance stage of memory differentiation (Figure 2B).
Genomic DNA was isolated from purified LCMV gp33-specific
CD8+ T cells harvested at varying time points after acute
LCMV infection. Naive, effector, and memory CD8+ T cells
were sorted to >95% purity based on gp33 class I tetramer
staining (see Figure S1 available online) and the percent of
DNA methylation at the Pdcd1 locus was analyzed by bisulfite
sequencing. Naive cells were nearly 100% methylated at CpG
sites 5 through 14 (Figure 2C), whereas CpG sites 5 through 14
in antigen-specific day 4 effector T cells were 75%–100% unme-
thylated. Interestingly, antigen-specific day 8 effector CD8+
T cells have already remethylated some of the CpG sites in
CR-C and CR-B compared to day 4 effector cells (Figure 2C).
Moreover, the reinstated DNA methylation program becomes
much more distinct in memory cells, with the majority of the
CpG sites in CR-B >70% remethylated. Interestingly, CpG sites402 Immunity 35, 400–412, September 23, 2011 ª2011 Elsevier Inc.5, 11, and 14 were observed to be unmethylated on 30% or
more of the alleles from the memory CD8+ T cells. These results
indicate that the transient upregulation in expression of PD-1
protein and transcript in virus-specific CD8+ T cells during their
differentiation from a naive CD8+ T cell to a day 8 effector
CD8+ T cell is associated with a transient demethylation of the
Pdcd1 locus (Figure 2).
To test whether recovery of the methylation profile in memory
CD8+ T cells is due to remethylation rather than selective death
of terminal effector cells, we measured the methylation status
in day 8 terminal effector (Klrg1hiIL7Ralo) and memory precursor
(Klrg1loIL7Rahi) subsets (Figure 2D; Kaech et al., 2003; Sarkar
et al., 2008). We found that the percent of methylation at CR-C
and CR-B of Pdcd1 was strikingly similar between the effector
subsets (Figure 2D). Thus, day 8 terminal effector and memory
precursor CD8+ T cells retain the same capacity to remethylate
the Pdcd1 locus. The reinstatement of the methylation program
in day 8 effector cells suggests that the recovery of the methyla-
tion occurs because of an enzyme-catalyzed process rather
than selective death of terminal effector cells, probably a conse-
quence of cessation of TCR signaling.
Chronic Viral Infection Inhibits DNA Remethylation
of the Pdcd1 Locus
In contrast to an acute viral infection, upregulation of PD-1
protein and transcriptional expression is maintained in antigen-
specific CD8+ T cells in the presence of persistent viral infection
(Figures 3A and 3B). To investigate the effect of prolonged
TCR stimulation on the PD-1 methylation program, we mea-
sured Pdcd1 CR-C and CR-B methylation in LCMV-specific
CD8+ T cells during chronic LCMV infection. LCMV-specific
CD8+ T cells were sorted to greater than 95% purity at 8 and
>30 days postinfection (Figure S1). We observed that the CpG
sites in CR-C and CR-B were demethylated in antigen-experi-
enced cells at day 8 after LCMV clone-13 infection and remained
demethylated >30 days after LCMV clone-13 infection subse-
quent to the contraction of the virus-specific CD8+ T cell popula-
tion (Figure 3C).
We next sought to determine whether duration of TCR stimu-
lation provides a real-time signal to maintain the demethylated
state of the Pdcd1 regulatory regions. To test this, we varied
the amount of TCR stimulation that virus-specific CD8+ T cells
would receive by infecting mice with either 2 3 105 or 2 3 106
pfu of LCMV Armstrong or 2 3 106 LCMV clone-13. LCMV-
specific CD8+ T cells were analyzed at 8 days postinfection.
Indeed, loss of DNA methylation of Pdcd1 CR-B in virus-specific
CD8+ T cells correlated with the duration of TCR stimulation
(Figure 3E), with the most demethylation observed in CD8+
T cells from animals infected with 2 3 106 pfu of LCMV clone-
13 and the least demethylation in CD8+ T cells from animals
infected with 2 3 105 pfu of LCMV Armstrong. We then pro-
ceeded to measure the percent of DNA methylation in virus-
specific CD8+ T cells from mice that had been treated with the
CD4-depleting antibody GK1.5 then chronically infected. Both
CR-C and CR-B remained demethylated in CD8+ T cell isolated
frommice at 40 days after LCMV clone-13 infection without CD4
help (Figure 3F). These data further support the finding that
the lack of DNA remethylation of Pdcd1 in exhausted CD8+
T cells (Figures 3C and 3F) is a consequence of TCR signaling
Figure 2. DNA Methylation of Pdcd1 CR-C and CR-B Is Inversely Correlated with PD-1 Expression in Antigen-Specific Cells from Mice
Acutely Infected with LCMV
(A) Histogram analysis of PD-1 protein expression on antigen-specific CD8+ T cells at 4, 8, and >30 dpi during acute infection with 23 105 pfu of LCMVArmstrong.
Red line indicates LCMV-specific CD8+ T cells; filled gray histogram indicates naive CD8+ T cells.
(B) Real-time PCR analysis of PD-1 transcript from purified naive, day 4 effector, day 8 effector, and memory antigen-specific CD8+ T cells. Error bars were
generated with the SEM from triplicate experiments.
(C) Bisulfite sequencing analysis and graphical summary of Pdcd1 CR-C and CR-B from FACS-purified naive, day 4 effector, day 8 effector, and memory cells.
(D) Bisulfite sequencing of Pdcd1 CR-C and CR-B was performed on genomic DNA from terminal effector and memory precursor CD8+ T cell subsets purified
frommice at 8 days postinfectionwith 23 105 LCMVArmstrong. Filled circles indicatemethylated cytosine. Each line represents a sequenced clone. Open circles
indicate nonmethylated cytosine. CpG sites 1–14 correspond to sites1280,1158,1099,1069,986,778,672,667,636,612,535,496,491,
and 465.
Error bars were generated with the SEM from triplicate experiments.
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a chronic infection.
PD-1 Expression in Virus-Specific CD8+ T Cells
Is Coupled to Chromatin Accessibility
Changes in DNA methylation are often accompanied with
changes in chromatin accessibility by transcription factors
and RNA polymerase. The ‘‘off-on-off’’ expression of PD-1 thatImoccurs during an acute antiviral CD8+ T cell response along with
the observed dynamic methylation of Pdcd1 CR-C and CR-B
(Figure 2) prompted us to determinewhether TCR ligation actively
signals for chromatin accessibility at the Pdcd1 regulatory
regions.DNase I hypersensitivity of thePdcd1-conserved regions
was assayed in antigen-specific CD8+ T cells from acutely in-
fectedmice before and after viral clearance to determinewhether
changes in Pdcd1 chromatin accessibility correlate with antigenmunity 35, 400–412, September 23, 2011 ª2011 Elsevier Inc. 403
Figure 3. Chronic Antigen Exposure Results in Prolonged Demethylation of Pdcd1 CR-C and CR-B
(A) Histogram analysis of PD-1 protein expression on antigen-specific CD8+ T cells during acute infection at 4, 8, and 60 dpi with 23 106 pfu of LCMV clone-13.
Red line indicates LCMV-specific CD8+ T cells; filled gray histogram indicates naive CD8+ T cells.
(B) Real-time PCR analysis of PD-1 transcript from purified naive and exhausted antigen-specific CD8+ T cells.
(C) Bisulfite sequencing analysis and graphical summary of Pdcd1CR-C and CR-B from FACS-purified antigen-specific cells at 8 and >30 dpi frommice infected
with LCMV clone-13.
(D) PD-1 expression was measured on the LCMV-specific CD8+ T cells harvested at day 8 postinfection from the acutely (2 3 105 and 2 3 106 pfu of LCMV
Armstrong) and chronically (2 3 106 pfu of LCMV clone-13) infected mice.
(E) Bisulfite sequencing and collective summary of CpG methylation at all sites in Pdcd1 CR-B was performed on purified day 8 effector cells.
(F) Bisulfite sequencing analysis and graphical summary of CR-C and CR-B in fully exhausted antigen-specific cells at 40 days postinfection from CD4-depleted
chronically infected mice.
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Epigenetic Regulation of PD-1 in CD8+ T Cellspresentation (Figure 4). Antigen-specific CD8+ T cells from mice
acutely infected with LCMV Armstrong exhibit a significant
increase in sensitivity to DNase I treatment at CR-C in PD-1hi
effector cells at 4 days postinfection only relative to naive,
PD-1lo day 9 effector, and memory antigen-specific CD8+
T cells (Figures 4B and 4C). In contrast to virus-specific CD8+
T cells obtained from mice infected with the acute strain of
LCMV, virus-specific CD8+ T cells from mice infected with the
chronic strain of LCMV were more sensitive to DNase I digestion
at bothCR-CandCR-B, indicating that the transcriptional regula-
tory regions aremore accessible (Figures 4B and 4C). These data
suggest that cessation of TCR signaling ultimately results in
restricting transcription factors from accessing the Pdcd1 locus.404 Immunity 35, 400–412, September 23, 2011 ª2011 Elsevier Inc.DNA methylation is utilized in concert with other epigenetic
mechanisms, including histone modifications, to program cell-
specific restriction of transcription factors to select regions of
chromatin. To further determine whether the chromatin at
Pdcd1 regulatory regions acquires epigenetic programs for
transcriptional repression in PD-1lo cells, we measured histone
trimethylation at histone 3 lysine 9 and 27 (H3K9me3 and
H3K27me3) via chromatin immunoprecipitation. Naive CD8+
T cells were observed to have very little repressive histone
marks despite their low amount of PD-1 expression. Interest-
ingly, we observed that PD-1lo antigen-specific effector CD8+
T cells generated from an acute viral infection are enriched for
these repressive marks relative to both naive CD8+ T cells and
Figure 4. CR-C Chromatin Is Hypersensitive to
Digestion by DNase I in PD-1hi Virus-Specific
CD8+ T Cells
(A) Experimental setup for generating antigen-specific
transgenic cells at 4, 9, and >40 dpi with LCMV clone-13 or
Armstrong. Viremia is detectable only inmice infectedwith
clone-13 at 9 dpi versus mice infected with Armstrong at 9
dpi (data not shown).
(B) Histogram panels show PD-1 expression on naive
(shaded gray line), LCMV Armstrong differentiated (open
blue line), and LCMV clone-13 differentiated (open red line)
P14 LCMV-specific CD8+ T cells.
(C) Relative DNase I hypersensitivity for CR-C and CR-B in
the Pdcd1 regulatory region of naive, day 4 effector, day 9
effector, and memory CD8+ T cells is plotted. p values
were determined with the Student’s t test. Not shown,
the p value for the difference in DNase I hypersensitivity of
CR-C between naive and day 4 effector cells is <0.005.
(D) Chromatin immunoprecipitation analysis for histone 3
lysine 9 trimethylation (H3K9me3) and histone 3 lysine 27
trimethylation (H3K27me3) at Pdcd1CR-Cwas performed
on chromatin extracted from the purified naive, D8 effector
Armstrong, and D8 effector clone-13 CD8+ T cells. The
bar graphs were generated from an average of three
independent experiments.
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mice (Figures 4D and S2). These data further suggest that
effector differentiation and the cessation of TCR signaling is
required for the acquisition of new epigenetic programs for
gene expression.
Exhausted CD8+ T Cells from Chronic Infection
Are Poised for Rapid PD-1 Re-expression
Based on the previous observation that DNA remethylation is
coupled with reduction of virus and PD-1 expression in the
generation of functional memory CD8+ T cells from acute
LCMV infection (Figure 2), we sought to determine whether
reduction in antigen presentation to antigen-specific CD8+Immunity 35, 400–4T cells from chronically infected animals would
also result in remethylation of the Pdcd1 locus.
LCMV clone-13 viremia is undetectable at
3–4 months postinfection and virus titers are
reduced in most tissues except for the kidney
and brain (Shin et al., 2007; Wherry et al.,
2003). Subsequent to the waning virus titer,
PD-1 expression is reduced on the LCMV-
specific T cells (Figure S3). PD-1lo LCMV-
specific CD8+ T cells from chronically infected
mice with nondetectable titers of virus in the
serum at 135 days postinfection with LCMV
clone-13 were sorted to greater than 95% purity
(Figure 5A), and bisulfite sequencing of Pdcd1
CR-C and CR-B was performed on the purified
genomic DNA (Figure 5B). Surprisingly, we
found that Pdcd1 CR-C and CR-B were still fully
unmethylated (Figure 5B).
We next assessed whether adoptively trans-
ferred LCMV-specific TCR transgenic CD8+
T cells (P14) would also maintain an unmethy-lated Pdcd1 CR-C and CR-B as a result of prolonged TCR
stimulation. Prior to LCMV clone-13 infection, we transferred
endogenous levels of congenically labeled P14s into mice. After
180 days postinfection, we analyzed themethylation status in the
adoptively transferred LCMV-specific CD8+ T cells. Indeed, the
continuous maintenance of an unmethylated regulatory region
that occurs during the chronic infection establishes a heritably
demethylated state in the adoptively transferred virus-specific
CD8+ T cells. Thus, naive CD8+ T cells start with the potential
to obtain either a functional memory CD8+ T cell epigenetic
program or an exhausted epigenetic program, and the commit-
ment to these programs is dictated by the duration of antigen
persistence (Figure 5C).12, September 23, 2011 ª2011 Elsevier Inc. 405
Figure 5. Prolonged Antigen Exposure Results in an Inability for Antigen-Specific CD8+ T Cells to Reinstate the Epigenetic Program
(A) PD-1 expression at day 8, 30, and 135 after LCMV clone-13 infection reveals that PD-1 expression decreases subsequent to the clearance of virus. Serum
virus titers (PFU/ml) for days 8, 30, and 135 postinfectionwere 63 104, 63 103, and undetectable, respectively. Day 135 p.i., antigen-specific cells were sorted for
methylation analysis.
(B) Methylation analysis of DNA from antigen-specific naive CD8+ T cells and virus-specific CD8+ T cells isolated from clone-13-infected mice at >135 dpi.
(C) Endogenous levels (200) of transgenic P14 CD8+ T cells specific for the LCMV antigen gp33-41 were adoptively transferred into WT B6mice. Chimeric mice
were infected the next day with 23 106 pfu of LCMV clone-13. Bisulfite sequencing was performed on purified adoptively transferred LCMV-specific CD8+ T cells
180 dpi.
(D) Congenically marked antigen-specific PD-1lo cells from either immune mice or chronically infected mice were cultured for 0, 6, and 12 hr in media containing
the gp33 peptide. FACS analysis of PD-1 re-expression in virus-specific CD8+ T cells from the long-term chronic environment (blue line) and from the acute
environment (red line) (gated on Thy1.1+ cells).
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Pdcd1 in exhausted CD8+ T cells implies that the locus is poised
for early transcriptional activation during a secondary immune406 Immunity 35, 400–412, September 23, 2011 ª2011 Elsevier Inc.response. To determine whether DNA remethylation is utilized
to control PD-1 re-expression during a secondary encounter
with antigen, we measured the kinetics of PD-1 expression
Figure 6. Persistent TCR Stimulation
Results in Downregulation of the Stem Cell
Isoform of the De Novo Methyltransferase
Dnmt3a
The relative expression of maintenance and de
novo methyltransferase mRNA was measured via
real-time RT-PCR. Analysis was performed on
cDNA generated from total RNA from naive, day 4,
day 8, memory, and exhausted LCMV-specific
CD8+ T cells. The difference in expression of
isoform 1 and isoform 2 of the de novo methyl-
transferase Dnmt3a was determined with two
different sets of primers that distinguish between
the two isoforms. Transcript expression values
were normalized to 18S ribosomal RNA. p values
were determined with the Student’s t test from
triplicate experiments.
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Epigenetic Regulation of PD-1 in CD8+ T Cellsfrommemory PD-1lo cells with or without DNAmethylation of the
Pdcd1 CR-C and CR-B. Highly functional LCMV-specific
memory CD8+ T cells from acutely infected animals or less
functional exhausted PD-1lo LCMV-specific CD8+ T cells from
chronically infected animals were ex vivo stimulated for 6 and
12 hr with the LCMV peptide gp33-41 (Figure 5D). We observed
that TCR-mediated stimulation of both populations of cells
resulted in increased PD-1 expression, but maximal PD-1
expression was achieved from LCMV-specific cells from the
chronically infected mice much faster relative to the LCMV-
specific CD8+ T cells from immune mice (Figure 5D). The greater
rate of PD-1 protein re-expression on the LCMV-specific cells
from the chronically infected mice relative to the LCMV-specific
cells from acutely infectedmice is consistent with the hypothesis
that the remethylation of fully functional memory cells serves as
a repressive mark for expression. Thus, the poised transcrip-
tional status of antigen-specific PD-1lo cells generated from
a prolonged infection may prematurely terminate a secondary
effector response via premature PD-1 signaling.
DNA Methyltransferase 3a Isoform 2 Expression
Is Decreased in Exhausted CD8+ T Cells
The differentiation of stem cells into cells with specialized func-
tions is coupled to the restricted expression of different isoforms
of de novo DNA methyltransferases (Chen et al., 2002; La Salle
and Trasler, 2006). It has previously been noted that isoform 2
of the de novo DNA methyltransferase Dnmt3a is expressed in
embryonic stem cells but downregulated in cells from various
tissues. Interestingly, a significant amount of Dnmt3a isoform
2 expression was also detected in cells from the spleen and
thymus (Chen et al., 2002). To determine whether the antigen-
driven commitment of naive CD8+ T cells toward a functional
versus nonfunctional memory fate is associated with restriction
of de novo DNA methyltransferase expression, we measured
the relative amount of transcript of both de novo and mainte-
nance DNA methyltransferases in antigen-specific CD8+ T cellsImmunity 35, 400–412, Segenerated from acute or chronic viral
infection. Interestingly, Dnmt3a isoform
2 (Dnmt3a2) expression was downregu-
lated in exhausted cells 18- and 7-
fold relative to the expression in day 4effector and functional memory CD8+ T cells, respectively.
However, isoform 1 of Dnmt3a (Dnmt3a1) was not downregu-
lated in exhausted CD8+ T cells (Figure 6). Furthermore, the
maintenance methyltransferase Dnmt1 was upregulated 6-
fold in day 4 effector cells during acute LCMV infection relative
to naive cells but was not significantly different in expression
between functional memory and exhausted virus-specific
CD8+ T cells (Figure 6). Furthermore, we found that naive CD8+
T cells have several unmethylated CpGs flanking the CpG island
upstream of the transcriptional start site of Dnmt3a2, whereas
exhausted CD8+ T cells acquired additional DNA methylation
at these CpG sites (Figure S4). The increased DNA methylation
at the CpGs upstream of the transcriptional start site of Dnmt3a2
in exhausted CD8+ T cells is consistent with reduced expression
of this Dnmt isoform. Our results showing specific downregula-
tion of Dnmt3a2 expression in exhausted cells is consistent
with the observation that virus-specific CD8+ T cells become
progressively restricted in function during chronic infection.
Epigenetic Regulation of PD-1 Expression
in Human Virus-Specific CD8+ T Cells
Results obtained from in vitro experiments on cell lines and
primary CD8+ T cells demonstrate that regulation of PD-1
expression is coupled to the ability to methylate the conserved
mammalian regulatory regions (Figure 1). Further, our in vivo
studies in mice demonstrated that demethylation and site-
specific remethylation of the Pdcd1 locus is coupled with devel-
opment of fully functional memory CD8+ T cells (Figure 2),
whereas exhausted CD8+ T cells maintained a demethylated
Pdcd1 locus. To determine whether this mechanism is utilized
in the context of regulating human antigen-specific CD8+ T cell
functions, we first determined whether changes in DNA methyl-
ation of the PDCD1 regulatory regions correlated with PD-1
expression in polyclonal naive (CCR7+CD45RA+) and PD-1hi
human CD8+ T cells. Human CD8+ T cells were obtained from
PBMCs of healthy human donors and sorted to a purity ofptember 23, 2011 ª2011 Elsevier Inc. 407
Figure 7. PDCD1 CR-C Is Remethylated during Effector to Memory Differentiation but Remains Demethylated in CD8+ T Cells Specific to
Human Viruses that Cause Chronic Infections
(A) Histogram analysis of PD-1 expression on naive and virus-specific CD8+ T cells. Bisulfite sequencing and graphical summary of CR-C of the PDCD1 promoter
in human naive (CCR7hi, CD45RAhi, PD-1lo), YF-17D-specific effector, and YF-17D-specific memory CD8+ T cells.
(B) Histogram analysis of PD-1 expression on virus-specific CD8+ T cells. Bisulfite sequencing and graphical summary of CR-C CpG sites 18–26 of the PDCD1
promoter in CMV- and EBV-specific CD8+ T cells (cytomegalovirus and Epstein-Barr virus). CpG sites 1–17 reside inside the predicted CpG island, which remains
predominantly demethylated (Figure S5). Histogram analysis of PD-1 expression is above the corresponding methylation summary. PD-1 expression of the naive
cells is shown with the shaded gray line, and PD-1 expression on the antigen-specific CD8+ T cells is indicated by the open black line.
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Epigenetic Regulation of PD-1 in CD8+ T Cells>94% (Figure S5; Day et al., 2006; Sallusto et al., 1999; J.D. and
R.A., unpublished results). We found that CpGs in the 50 region of
CR-C in polyclonal human naive cells weremore than 70%meth-
ylated (Figure 7A), similar to the observed level of methylation in
mouse naive CD8+ T cells (Figure 2). We next measured the
methylation of PDCD1 CR-C in polyclonal antigen-experienced
(CCR7) PD-1hiCD8+ T cells and polyclonal antigen-experienced
PD-1loCD8+ T cells. PDCD1 CR-C was fully demethylated in
the antigen-experienced PD-1hiCD8+ T cells, whereas it was
intermediately methylated in antigen-experienced PD-1loCD8+
T cells relative to the naive cells (Figure S6).
We next proceeded to perform the methylation analysis
on human virus-specific effector and memory CD8+ T cells. A
primary immune response to the live virus yellow fever vaccine
results in expansion of an MHC class I tetramer+ effector CD8+
T cell population specific for an NS4B epitope between day 15
and day 30 postvaccination. The expansion of the YF-17D-408 Immunity 35, 400–412, September 23, 2011 ª2011 Elsevier Inc.specific effector CD8+ T cells is coupled to the transient ex-
pression of PD-1. After contraction of the YF-17D-specific
CD8+ T cells and downregulation of PD-1 expression, a highly
functional memory population emerges (>90 days postvaccina-
tion) (Figure 7; Akondy et al., 2009; Miller et al., 2008). By using
the MHC class I tetramer for the YFV dominate epitope, we
sorted YF-17D-specific effector and memory CD8+ T cells to
>94% purity (Figure S5). Yellow fever virus-specific effector
CD8+ T cells were nearly completely demethylated relative to
naive CD8+ T cells, which were more than 70% methylated
(Figure 7A). After the contraction phase of the CD8+ T cell
response to the infection, yellow fever virus-specific memory
CD8+ T cells recovered a substantial level of DNA methylation
at PDCD1 CR-C. Interestingly, the site-specific lack of methyla-
tion at CpG site 21 in yellow fever virus-specific memory CD8+
T cells relative to naive cells is strikingly similar to the reduced
level of methylation in yellow fever virus-specific effector CD8+
Immunity
Epigenetic Regulation of PD-1 in CD8+ T CellsT cells (Figure 7A). This is consistent with the idea that human
memory CD8+ T cells transitioned through an effector stage of
differentiation.
Subsequent to our epigenetic analysis of CD8+ T cells gener-
ated from an acute viral infection, we proceeded to determine
whether chronic infections in humans would result in a retained
demethylated state of the PDCD1 locus. Antigen-experienced
PD-1hiCD8+ T cells generated in response to Epstein-Barr virus
(EBV) or cytomegalovirus (CMV) infection were obtained from
PBMCs of human donors. The antigen-specific CD8+ T cells
were sorted to >94% purity via class I tetramers (Figure S5).
We found that CMV- and EBV-specific CD8+ T cells have no
methylation of the PDCD1-conserved region (Figure 7B). Taken
together, these results suggest that persistent TCR signaling to
CD8+ T cells results in the maintenance of PDCD1 regulatory
region demethylation, leaving the locus poised for rapid tran-
scriptional activation and a premature dampening of the effector
response resulting from PD-1 signaling (Figures 7A and 7B).
DISCUSSION
Phenotypic differences between functional versus nonfunctional
antigen-specific memory CD8+ T cells are largely manifested
through changes in transcriptional regulation (Kaech et al.,
2002; Slifka and Whitton, 2001; Wherry et al., 2007). The mech-
anism for programming unique transcriptional profiles of
memory CD8+ T cells is not well understood, but the cell-trans-
missible nature of memory functions during the self-renewal
process indicates that epigenetic modifications are utilized to
adapt the naive transcriptional programs intomemory programs.
Epigenetic modifications serve as a mechanism to instruct
nucleosomal modifying factors to restrict access to specific
regions of chromatin. Specifically, adaptation to epigenetic
modifications during an immune response to viral infection
may account for the acquired transcriptional profile of memory
CD8+ T cells.
We have shown here that both mouse and human antigen-
specific CD8+ T cells that differentiate in response to acute viral
infection develop a memory-specific epigenetic program at the
PDCD1 conserved regions. The program arises through rein-
stating the methylation after the removal of the naive program
at the effector stage of differentiation. Interestingly, the remethy-
lation process that occurs before T cell contraction ignores
select CpG sites. In particular, CpG sites 5 and 14 in the mouse
and CpG site 21 in the human remain partially demethylated. The
retained demethylation of specific sites in the memory cells
suggests that there may be a memory-specific T cell program
or mechanism for Pdcd1 transcriptional regulation that is
different from the naive program. The observation that terminal
effector and memory precursors subsets of the effector popula-
tion both recover DNA methylation indicates that the memory-
specific epigenetic program arises because of signaling events
that both cellular populations experience. This is consistent
with prior work showing that memory CD8+ T cells transition
through the effector stage of differentiation (Jacob and Balti-
more, 1999; Kaech et al., 2003; Sarkar et al., 2008). Furthermore,
in microarray studies comparing gene expression profiles of
terminal effector and memory precursor subsets, significantly
fewer differences in gene expression are observed betweenImthe subsets versus differences when compared to naive or
memory CD8+ T cells (Kalia et al., 2010; Sarkar et al., 2008).
Therefore, any differential epigenetic programming associated
with either subset may be limited, probably restricted to amaster
regulatory factor.
In contrast to an acute infection, where clearance of the path-
ogen results in a heightened functional capacity of antigen-
specific CD8+ T cells, the continual exposure of antigen during
chronic infections results in progressive functional impairment
of T cells. Indeed, we show here that the mechanism for site-
specific DNA remethylation in both mouse and human is lost in
CD8+ T cells when antigen persists in the context of chronic
infection. Interestingly, when we used a viral infection model
system that maintains high viremia for several months but
eventually resolves to an undetectable titer of infection (LCMV
clone-13), we observed that PD-1 expression was diminished
on virus-specific CD8+ T cells, yet the repressive DNA methyla-
tion marks were not reinstated. Further, the lack of remethylation
is observed in two different human virus-specific CD8+ T cell
populations generated in response to two chronic viral infec-
tions, demonstrating that the retained demethylation of the
PDCD1 locus is a result of persistent antigen. This suggests
that antigen-specific CD8+ T cells have a restricted timeframe
for remethylation of the PDCD1 regulatory regions.
The heritable loss of chromatin-repressive marks in chronic
antigen environments at promoters of immunoinhibitory recep-
tors such as PD-1 may predispose antigen-specific T cells to
receive more inhibitory signals, resulting in diminished T cell
function. Indeed, we observed that PD-1lo antigen-specific
CD8+ T cells from a chronic environment reach maximal PD-1
expression much faster than functional memory cells upon
ex vivo stimulation. The striking difference in the DNA methyla-
tion program for PD-1 expression in highly functional versus
less functional virus-specific CD8+ T cells arising from acute
versus chronic infection emphasizes two fundamental properties
of CD8+ T cell memory differentiation: (1) CD8+ T cell memory
fates are not predetermined but rather are a consequence of
the environment; and (2) the epigenetic mechanism of DNA
methylation in CD8+ T cells is a pliable program mediated by
extracellular cues. Microarray studies between functional
memory and exhausted CD8+ T cells have reported a large
number of differentially expressed genes; thus, it will be inter-
esting to see whether other genes acquire antigen duration-
dependent epigenetic modifications during CD8+ T cell memory
differentiation.
Several recent studies have called attention to the role tran-
scription factors play in memory CD8+ T cell differentiation
(Rutishauser et al., 2009; Shin et al., 2009). Indeed, the accumu-
lating evidence suggests that certain transcription factors, often
referred to as master regulators, mediate cell fate decisions by
instituting a lineage-specific pattern of transcriptional activation
(Rothenberg, 2007). The convergence of our work highlighting
the importance of epigenetic programming in T cell differentia-
tion with work defining T cell lineage transcriptional regulatory
networks puts forth the idea that transcription factors may be
directing epigenetic programs. Based on the prior observation
that the transcription factor NF-ATc1 interacts with the Pdcd1
promoter at CR-C (Oestreich et al., 2008), we performed a
bioinformatics analysis of putative transcription factors sitesmunity 35, 400–412, September 23, 2011 ª2011 Elsevier Inc. 409
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PROMO. The consensus sequence for NF-AT is indeed found
near mouse CpG sites 1099 and 1069, prompting specula-
tion that NF-AT may bind within a nucleosomal footprint of the
demethylated CpG sites 1069, 986, and 465 in memory
CD8+ T cells. A causal relationship between NF-ATc1 and epige-
netic programming is yet to be determined. Further under-
standing of the temporal relationship between localization of
transcription factors, such as NF-AT, and epigenetic modifica-
tions at lineage-specific genes is needed to better define the
mechanism for commitment to a memory CD8+ T cell fate and
potentially provide a means for reprogramming exhausted
CD8+ T cells to obtain a fully functional antiviral response.
The findings presented here on bothmouse and human epige-
netic control of PD-1 expression highlight the adaptable nature
of DNAmethylation in CD8+ T cells undergoing infection-induced
differentiation. The data presented here emphasize transcrip-
tional regulation of PD-1 as a potential target for epigenetic
reprogramming with the goal of recovering antiviral functions in
exhausted antigen-specific CD8+ T cells. Because of the global
changes in gene expression observed in nonfunctional CD8+
T cells, future studies will need to define to a broader degree
the changes that occur to the CD8+ T cell epigenome during
chronic infection and the consequence of these changes on
CD8+ T cell adaptive immunity.
EXPERIMENTAL PROCEDURES
Generation of Antigen-Specific T Cells
Wild-type C57BL/6 mice (Jackson Laboratory) were acutely or chronically
infected with lymphocytic choriomeningitis virus Armstrong (2 3 105 pfu i.p.)
or clone-13 (2 3 106 pfu i.v.), respectively (Matloubian et al., 1990; Wherry
et al., 2003). PD-1hi effector cells are obtained at 4 dpi and PD-1lo at 8 dpi.
Memory CD8+ T cells were harvested at >40 dpi from immunemice. Exhausted
CD8+ T cells were generated by infecting mice with LCMV clone-13 (Barber
et al., 2006; Wherry et al., 2007; Zajac et al., 1998). CD4+ T cell depletion
was performed by treating mice with 500 mg of GK1.5 at 1 and 0 day postin-
fection. All CD8+ T cells were harvested from the spleen. Antigen-specific
CD8+ T cells were purified by fluorescence activated cell sorting (FACS) by
H-2Db tetramers bound to LCMV peptide GP33-41 and GP276-286 conju-
gated to a fluorophore, along with a CD8-fluorophore-conjugated antibody
as previously described (Murali-Krishna et al., 1998).
Transgenic P14 cells with an engineered TCR that recognize the epitope
GP33-41 of LCMV were harvested from naive mice and adoptively transferred
intravenously to C57BL/6 mice (either 2000 or 1 3 105 antigen-specific CD8+
T cells per mouse as specified in the figure legend) to generate LCMV-specific
CD8+ T cell chimeras (Blattman et al., 2002; Kersh, 2006; Kersh et al., 2006).
Chimeric CD8+ T cells were sorted via fluorescently labeled CD90.1 (Thy1.1)
andCD8 antibodies as previously described (Murali-Krishna et al., 1998). Naive
antigen-specific cells obtained from transgenic P14 mice (Pircher et al., 1989)
were used as an antigen-specific naive control to compare with effector,
memory, and exhausted CD8+ T cells. All mice were used in accordance with
the Emory University Institutional Animal Care and Use Committee Guidelines.
Ex vivo culture of antigen-specific splenocytes was performed as previously
described (Wherry et al., 2003). In brief, for cytokine analysis, 1 3 106 spleno-
cytes were cultured for 5 hr in a 96-well round bottom plate containing 200 ml
of media (RPMI, 10% FBS, L glutamine, 200 ng/ml gp33 peptide, and Golgi-
plug). Cytokine staining was performed per the instruction of the Cytofix/
Cytoperm kit (Becton Dickenson). Cell culture experiments lasting longer
than 5 hr were performed in 96-well flat bottom plates without Golgi-plug.
Human naive and antigen-experienced CD8+ T cells were obtained from
blood from healthy subjects after informed consent, and approval for all
procedures was obtained from the Emory University Institutional review board.
Whole blood was collected in cell preparation tubes (BD) and processed410 Immunity 35, 400–412, September 23, 2011 ª2011 Elsevier Inc.for PBMCs as previously described (Akondy et al., 2009). Bulk CD8+ T cells
were sorted by FACSbased onCD3hi andCD8hi gating. This subsetwas further
divided into CCR7hi, CCR7lo, and PD-1hi populations. The naive population
was defined byCCR7hi andCD45RAhi, and the effector populationwas defined
by CCR7lo and PD-1hi. Cytomegalovirus, Epstein-Barr virus, and yellow fever
vaccine antigen-specific cells were sorted from PBMC with HLA class I tetra-
mers. For isolation of YFV-, CMV-, or EBV-specific CD8+ T cells, PBMCs were
first incubated for 30 min with the YF-A2, CMV-A2, or EBV-A2-streptavidin
APC class-I tetramer complexes, followed by a further 30 min incubation
with CD19-FITC, CD14-FITC, CD4-FITC, CD56-FITC, and CD8-PE.
Genomic Methylation Analysis
Bisulfite-induced deamination of unmethylated cytosines and sequencing
of the target genomic region were used to measure the allelic frequency of
methylated cytosines (Trinh et al., 2001). Bisulfite modification was performed
with the Zymo Research EZ DNA methylation kit. The bisulfate-modified DNA
was PCR amplified with locus-specific primers (Table S1). The PCR amplicon
was cloned into the pGEM-T TA cloning vector (Promega), then transformed
into XL10-Gold ultracompetent bacteria (Stratagene). Individual bacterial
colonies were grown overnight, and the cloning vector was purified and the
genomic insert sequenced.
DNase Hypersensitivity Assay
Naive, effector, and memory P14 CD8+ T cells were purified to >60% purity by
labeling cells with a Thy1.1-biotin antibody (Becton Dickenson) followed by
streptavidin magnetic bead (Miltenyi) column isolation. All cell populations
were simultaneously treated with the same stock of DNase I. Conditions for
DNase treatment were adapted from the previously described protocol (Oes-
treich et al., 2008). In brief, nuclei from 5 3 105 cells were extracted with the
DNase buffer (10 mM HEPES [pH 8.0], 50 mM KCl, 5 mM MgCl2, 3 mM
CaCl2, 0.1% V/V NP40, 8% V/V glycerol, 1 mM DTT) (Lu and Richardson,
2004). Cells were brought up in DNase buffer followed by 10 strokes with a
pipetman and incubated on ice for 5 min. Nuclei were then incubated at
room temperature with 5 units of DNase I for 3 min. The assay was then
quenched with DNase stop buffer (20 mM EGTA and 1% W/V SDS) (Lu and
Richardson, 2004). Samples were incubated with Ribonuclease A for 2 hr at
37C and then incubated overnight at 55C with Proteinase K. DNA was
purified by phenol chloroform extraction and ethanol precipitation. DNA
samples were brought up in 30 ml of 10 mM Tris. Relative hypersensitivity
was determined by quantifying the amount of retained chromatin with primers
specific to the genomic region of interest (Table S1). Relative fold change was
normalized back to samples that received no DNase I treatment.
In Vitro DNA Demethylation Assay
Naive humanCD8+ T cells were isolated fromPBMCs of healthy human donors
and sorted to >95% purity. The cells were cultured with anti-CD3 anti-CD28
beads to activate cells as previously described (Parry et al., 2005). 13 106 cells
were cultured in the presence and absence of the DNA demethylating
compound 5-aza-20-deoxycytidine (Sigma Aldrich) at a final concentration of
1 mM. 5-aza-20-deoxycytidine solutions were made fresh just prior to culturing
the cells. Cells were analyzed for transcript and protein expression at the given
time points listed in the Figures 1, 2, 3, and 6.
Real-Time PCR Analysis of mRNA
Total RNA was isolated from purified antigen-specific CD8+ T cells from naive
mice and mice infected with LCMV Armstrong and LCMV clone-13. RNA was
extracted from cells with the QIAGEN RNeasy kit per the instructions of the
manufacturer. Quantitative real-time PCR of PD-1 and Dnmt transcripts was
performed with primers as previously described (Table S1; La Salle et al.,
2004; La Salle and Trasler, 2006; Lucifero et al., 2007; Oestreich et al.,
2008). Transcript expression values were normalized to 18S ribosomal RNA.
Triplicate experiments were analyzed with Prism 4. Statistically significant
different transcript expression was assessed by a two-tailed unpaired
Student’s t test.
Histone Methylation Analysis
Chromatin immunoprecipitation (ChIP) was performed as previously described
(Beresford and Boss, 2001; Oestreich et al., 2008). In brief, chromatin was
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crosslinked with 1% formaldehyde, then precleared for 1 hr with protein
A beads. Crosslinked chromatin was immunoprecipitated overnight with the
antibodies described in the legend of Figure 4. After the IP, the beads were
washed and DNA was eluted. Crosslinks to the DNA were reversed by incu-
bation at 65C overnight. DNA was then purified and assayed by real-time
PCR. The values for ChIP-immunoprecipitated DNA were normalized to input
DNA and plotted as fold over the normalized values of irrelevant Ab control
(anti-HA). Each ChIP analysis was performed three times with chromatin from
independently purified CD8+ T cells. Anti-H3K9me3 and anti-H3K27me3
were purchased from Millipore.
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